Fathom Holdings Inc. to Report 2020 Fourth Quarter and Full-Year Financial Results and Host Conference Call on Tuesday, March 23, 2021
Get Alerts FTHM Hot Sheet
Join SI Premium – FREE
CARY, N.C., March 9, 2021 /PRNewswire/ -- Fathom Holdings Inc. (Nasdaq: FTHM), a holding company that primarily operates through its wholly owned subsidiary, Fathom Realty, LLC, a national, cloud-based, technology-driven, residential real estate brokerage, today announced it will release its 2020 fourth quarter and full-year financial results after market close on Tuesday, March 23, 2021. The Company will host an investor conference call the same day.
Call Date: Tuesday, March 23, 2021 Time: 5:00 p.m. ET/2:00 p.m. PT Phone: 833-685-0908 (domestic); 412-317-5742 (international) Replay: Accessible through March 30, 2021; 877-344-7529 (domestic); 412-317-0088 (international); replay access code 10153181 Webcast: Accessible at www.fathomrealty.com; archive available for approximately one year
About Fathom Holdings Inc.
Fathom Holdings Inc. is the parent company of Fathom Realty Holdings, LLC, a national, virtual, full-service real estate brokerage that leverages proprietary cloud-based software called IntelliAgent to operate a Platform as a Service model (PaaS) for the residential real estate industry. Fathom offers real estate professionals 100% commission, small flat-fee transaction costs, support, technology, and training, all powered by best-in-class operational efficiencies. For more information visit www.fathomrealty.com.
Investor Relations and Media Contacts:
Roger Pondel/Laurie Berman PondelWilkinson Inc. [email protected] (310) 279-5980
Marco Fregenal President and CFO Fathom Holdings Inc. [email protected] (888) 455-6040
View original content to download multimedia:http://www.prnewswire.com/news-releases/fathom-holdings-inc-to-report-2020-fourth-quarter-and-full-year-financial-results-and-host-conference-call-on-tuesday-march-23-2021-301243895.html
SOURCE Fathom Realty
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- XCMG Machinery Triumphs with the 2024 German Design Award for Outstanding Integrated Campaigns and Advertising
- 73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!